Wolf Rinke Associates

CPE Home Page

Frequently Asked Questions

List of All Courses/Programs
Quick way to order!

Nutrition & Clinical

CDEs / NCBDE

Prof. Development

Management

eCourses/ePrograms
Including FREE ETHICS

Bargain Corner/Sales

Share a Program:
Reporting Forms only

Non-CPEU Products

Become One of Our Authors

Order Form
For fax, mail, or Purchase Orders

Submit Reporting Form

FREE:Read & Grow Rich
eNewsletter-Sign up For Alerts
New programs/Special Offers/Coupons

FAQs

Contact Us


Diabetes Risks from Prescription and Nonprescription Drugs
Mechanisms and Approaches to Risk Reduction


Sam Dagogo-Jack, MD
Study Guide by Susan Burke March, MEd, RDN, LDN, CDE
Edited by Wolf J. Rinke, PhD, CSP, RDN

C301
11 CPEUs
HARD COPY
$104.95

Course Expires: 5/31/2024

Book, 133 pgs, and Study Guide with 1 Reporting Form, 27 pgs.

Discusses the impact of major drug classes on glycemic control in people with diabetes, and on the risk of drug-induced diabetes in the general population, debunking myths, and clarifying misperceptions. Conveniently organized by type and class of drugs it will enable you to:     

  • Evaluate antipsychotic and antidepressant medications for their potential to increase risk for diabetes.
  • Recommend to patients/clients evidence-based lifestyle modifications to manage glycemia.
  • Explain how Total Parenteral Nutrition (TPN) can impact risk for diabetes.
  • Explain the diabetes-related dangers of recreational drugs and impact on blood glucose.
  • Plus much, much more.

For more information and customer comments, click here.

Approved/Accepted byCDR, NCBDE

For RDs/RDNs & DTRs/NDTRs for the Professional Development Portfolio

SUGGESTED Learning Need Codes:
3000, 3010, 3060, 3070, 3090, 5000, 5110, 5120, 5160, 5190, 5250, 5320, 5350, 5360, 5370, 5410, 5420, 5440.

SUGGESTED Performance Indicators (PIs):
1.2.2, 6.1.4, 6.3.6, 8.1.1,8.1.2, 8.1.5, 8.3.1, 8.3.6, 10.1.1, 10.1.2,10.4.1, 10.1.3, 10.2.1, 10.2.2, 10.2.3, 10.2.4,  10.2.5, 10.2.7, 10.2.10, 10.4.1, 10.4.2, 10.4.3, 10.4.4, 10. 2. 7, 10.2.9, 12.4.6.

DON'T SEE your Performance Indicators or Code Listed here?
There are many Performance Indicators (PIs) that are applicable we can't list them all & Per CDR you may use ANY PI or CODE as long as it relates to your Learning Plan.
For details
click here.

Share with a friend and Save! Click here for important information about sharing.
To order an ADDITIONAL Reporting Form click below:

C301F 11 CPEUs
REPORTING FORM
$40.00

Diabetes Risks from Prescription and Nonprescription Drugs
Mechanisms and Approaches to Risk Reduction
Sam Dagogo-Jack, MD
Study Guide by Susan Burke March, MEd, RDN, LDN, CDE
Edited by Wolf J. Rinke, PhD, CSP, RDN

©2017 Wolf Rinke Associates. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, without the prior written permission of the Publisher.

CUSTOMER COMMENTS

Stacie M. Eby - "A lot of information; was presented well; just more than I expected."

Lori L. Johnson - "I enjoyed the book. A great reference tool. I learned new information that I will have at my fingertips."

Dawn J. Walker - "Chapter 7, Lipid-Lowering Drugs opened my eyes on a personal basis. I did not think about the diabetes risk when using these drugs. This will be useful to me and also from a professional level."

Jessica T. Deneke - "I am about to be a CDE in a pharmacy, so I really wanted to review medications for my diabetes patients and this course was great."

Toni L. Pflieger - "The course was very thorough and applicable for Diabetes Educators. I enjoyed the case studies the most. The only negative is that the print was very small and some of the tables were hard to read."

 

OVERVIEW AND INSTRUCTIONS

Welcome to the pre-approved, accredited CPE program for Diabetes Risks from Prescription and Nonprescription Drugs--Mechanisms and Approaches to Risk Reduction. The program consists of a book of the same title by Sam Dagogo-Jack, MD and this study guide. This CPE program is designed to provide you with useful knowledge regarding how medications and supplements can impact your patient’s health and risk for diabetes. It is also designed to help you earn 11 Level 2, Continuing Professional Education Units (CPEUs).

To get the most out of this CPE program, it is suggested that you adhere to the following four steps:

  • Review the objectives in this study guide.
  • Read and study the Pocket Guide.
  • Assess what you have learned by answering the self-assessment questions in this study guide.
  • Compare your answers to the answer key, which you will find at the end of the study guide. If you scored at least 80% (40 questions) correct, you have completed the program and are ready to transfer your answers to the CONTINUING PROFESSIONAL EDUCATION REPORTING FORM in front of this study guide. If you scored less than 80% correct, re-read the appropriate sections of the Pocket Guide until you score at least 80% (40 questions) correct.
  • After you have successfully completed the program, complete the CPE REPORTING FORM and:
    Submit on-line at www.easyCPEcredits.com,
    Or fax to: (410) 531-9282,
    Or mail to: Wolf Rinke Associates, 721 Valley Forge Road #486, Valley Forge, PA 19481
We will email your Certificate of Completion.

When you submit your CPE Reporting Form to us via www.easyCPEcredits.com, fax, or mail be sure to write your correct email address in the space provided on the CPE Reporting Form. If writing by hand, be sure to print your email address clearly.

To ensure that our emails are delivered to your inbox (instead of your junk/spam folders), please add cpesupport@wolfrinke.com to your Address Book or Safe List of allowed email senders. Also, be sure to allow attachments from this email address.

LEARNING OBJECTIVES

Upon completion of this CPE program you will be better able to:

  • Explain the classification, diagnostic criteria, and inherent and lifestyle risk factors for prediabetes, Type 1 and Type 2 diabetes.
  • Evaluate antihypertensive medications for their potential to increase the risk for diabetes, and discuss possible alternatives.
  • Explain steroid therapy and possible affects on blood glucose.
  • Assess how lifestyle intervention programs can impact risk for progression from prediabetes to diabetes.
  • Evaluate lipid-lowering agents for their risk for diabetes, and identify favorable alternatives.
  • Discuss organ transplantation and immunosuppressive medications, and associated risk factors for diabetes.
  • Explain how antimicrobial agents may impact health, weight, and blood glucose.
  • Evaluate approaches to management and risk reduction for patients with HIV-AIDS.
  • Assess how antiretroviral drugs are associated with increased risk for adverse metabolic effects.
  • Evaluate antipsychotic and antidepressant medications for their potential to increase risk for diabetes and assess appropriate medications for glycemic control.
  • Implement current research associated with gender, ethnicity, and diabetes risk.
  • Recommend to patients/clients evidence-based lifestyle modifications to manage glycemia.
  • Explain how Total Parenteral Nutrition (TPN) can impact risk for diabetes.
  • Assess how analgesic over-the-counter supplements and medications can impact blood glucose.
  • Explain the diabetes-related dangers of recreational drugs and impact on blood glucose.
  • Discuss the relationship between male testosterone status, supplemental therapy, and potential risk of diabetes.

TABLE OF CONTENTS

Chapter 1.Overview of Diagnosis, Classification, and Pathophysiology of Diabetes
Diabetes
Diagnosis of Diabetes and Prediabetes
Demographic Factors
Insulin Resistance
Conclusion
Chapter 2.Medications and Diabetes Risk: General Mechanisms
Risk Factor versus Causation: The Bradford Hill's Criteria
Drugs Associated with Type 1 Diabetes
Drugs Associated with Type 2 Diabetes
Chapter 3.Glucocorticoid, Mineralocorticoid, and Immunomodulatory Agents
Glucocorticoid Steroids
Mineralocorticoids: Aldosterone and Glucoregulation
Immunomodulatory Agents
Chapter 4.Sex Steroids and Gonadotropin-Releasing Hormone Analogs
Estrogens and Progestins

Androgens, Sex Hormone Binding Globulin, and Glucoregulation
Androgen-Deprivation Therapy with Gonadotropin-Releasing Hormone Agonists
Chapter 5.Antihypertensive Agents
Diuretics
B -Adrenoreceptorp Blockers
a-Adrenoreceptorp Blockers
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Calcium-Channel Blockers
Diazoxide and Other Peripheral Vasodilators
Other Agents
Chapter 6.Catecholamines, B-Adrenergic Agonists, and Bronchodilators
B-Adrenergic Agonists
Theophylline
Chapter 7.Lipid-Lowering Agents
Nicotinic Acid
Statins
Fibrates
Colesevelam and Bile Acid Sequestrants
Lipid-Lowering Drugs and Diabetes Complications
Chapter 8.Antimicrobial Agents
Antibiotics
Fluoroquinolones
Antiretroviral Agents
Chapter 9.Atypical Antipsychotic and Antidepressant Agents
Atypical Antipsychotic Agents
Antidepressants
Chapter 10.Recreational Drugs
Alcohol
Nicotine
Marijuana and Cannabinoids
Opioids
Cocaine, Amphetamine, and Psychostimulant Drugs
Chapter 11.Miscellaneous Agents:
Nonsteroidal Anti-Inflammatory Drugs, Glucosamine, and Acetaminophen
Thyroid Hormone
Phenytoin and Anticonvulsants
Growth Hormone
Total Parenteral Nutrition and Inpatient Hyperglycemia
Chapter 12.General Approach to Risk Reduction
Lifestyle Intervention for Diabetes Prevention
Limitations of Lifestyle Intervention
Medications for Diabetes Prevention
Limitations of Medications
Current Guidelines for Use of Medications for Diabetes Prevention
Diabetes Pharmacoprophylaxis
Index

ABOUT THE AUTHOR OF THE STUDY GUIDE

Over the past 25 years Susan Burke March, MEd, RDN, LDN, CDE has made her personal passion for healthy living and smart weight management her vocation.
Susan holds undergraduate and graduate degrees in nutrition and education, is a certified diabetes educator, and holds advanced certificates of training in Adult Weight Management (Levels 1 and 2) and Childhood and Adolescent Weight Management. She served as Chief Clinical Nutrition Manager at Mt. Sinai Hospital of Queens, New York.
Susan is the former Vice President of Nutrition and Chief Nutritionist for eDiets.com, a leader in the online weight management program arena. She led the nutritional development of a roster of healthy weight programs, and spearheaded development of unprecedented features and services that today are commonplace in the online weight management industry.
Susan served on the board of the Weight Management Dietetic Practice Group of the Academy of Nutrition and Dietetics, and as a spokesperson for the Florida Academy of Nutrition and Dietetics.
Susan is the author of the practical and informative book Making Weight Control Second Nature: Living Thin Naturally (Mansion Grove House, 2009) and the accompanying 26 CPEU study guide published by Wolf Rinke Associates (2010).
She and her husband Ken are currently living and studying Spanish in Ecuador’s third largest city, Cuenca. Susan is the Nutrition and Health Columnist for CuencaHighlife.com, and blogs on SecondNatureNutrition.com about Ecuadorian food, health issues, and nutrition news for the expat community.

ABOUT THE EDITOR OF THE STUDY GUIDE

Wolf J. Rinke, PhD, RDN, CSP is the president and founder of Wolf Rinke Associates, a company that has provided high quality CPE programs to nutrition professionals since 1990.
He earned a BS at Drexel University, a MS at Iowa State University, a PhD in Continuing and Vocational Education (Adult Ed) at the University of Wisconsin, and interned at Walter Reed Army Medical Center. He participated in a test item writer workshop sponsored by the Commission on Dietetic Registration (CDR).
Wolf is a past Adjunct Associate Professor, Graduate School of Management & Technology, University of Maryland, and a former Adjunct Faculty Member, School of Continuing Studies, The Johns Hopkins University.
He is the past president of the DC Dietetic Association and has been honored by the Academy with the Award for Excellence in the practice of Management; the Outstanding Dietitian of the Year Award; the Outstanding Service Award; and has delivered the Lenna Frances Cooper Lecture.
At the Academy he has served in numerous leadership roles including Chair, Scholarship Committee, DBC; Chair, Communication Committee, CDR; Chair, Area Coordinating Committee, COE; Chair, COE, and member of Resource for Education Programs Committee; Honors Committee; CDR, Licensure Panel and Ethical Practices Task Force; CDR; House of Delegates and Board of Directors.
He is the author of more than 500 articles, numerous CPE home-study programs, several popular books, and the free monthly eNewsletter Read and Grow Rich written specifically for savvy Nutrition Professionals like YOU!
Subscribe now at www.easyCPEcredits.com--you’ll be glad you did!

ACKNOWLEDGEMENTS

Special thanks to the following individuals for their careful review of this CPE program.

Janice Baker, MBA, RD, CDE, CNSC, BC-ADM
Certified Diabetes Educator, Certified Nutrition Support Clinician
San Diego, CA

Andrea Hebert, MS, RD, LD, CDE
Corporate and Wellness Nutrition
Nashua, NH

Kathleen Taylor, MS, RDN, LMNT
Diabetes Educator, Diabetes Program Coordinator
Beatrice, NB


If you prefer to order by phone, mail or fax click below

Order Form

or click here to contact us with other questions.

For information about our other products and services return to the sidebar at the top of the page.